A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

February 2, 2026

Study Completion Date

February 2, 2026

Conditions

Pemphigus DiseaseRituximab (RTx)Intravenous Immunoglobulin

Trial Locations (1)

Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors

lead

Ruijin Hospital

OTHER